To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
393 Current news of Bayerrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
The Supervisory Board of Bayer AG on Tuesday decided to reduce the size of the company’s Board of Management from seven to five members effective January 1, 2020. Dr. Hartmut Klusik (63) and Kemal Malik (56) will leave the company as of December 31, 2019. As part of the previously communicated ...
Bayer and LANXESS sell their stakes in the chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). Both companies signed corresponding agreements with MIRA on August 6, 2019. The transaction still requires the approval of the responsible authorities. ...
The Bayer Group achieved a strong start to the year in its operational business. “A major factor in this success was our agriculture business, while Pharmaceuticals also delivered encouraging performance,” said Werner Baumann, Chairman of the Board of Management, on Thursday when presenting the ...
Group sales and earnings increase
Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjusted ...
BASF has closed the acquisition of a range of businesses and assets from Bayer. The transaction is a strategic complement to BASF’s crop protection, biotech and digital farming activities and marks its entry into seeds, non-selective herbicides and nematicide seed treatments. “This strategic move ...
Another record year for Pharmaceuticals
In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically. “We took major steps toward the proposed acquisition of Monsanto,” Management Board Chairman Werner Baumann said on Wednesday at the Financial News Conference in Leverkusen. ...
The third quarter of 2017 marked a period of further strategic and operational progress for the Bayer Group. “Last quarter we took some important strategic steps,” said Werner Baumann, Chairman of the Board of Management, when he presented the interim report for the third quarter on Thursday. ...
Growth momentum across all segments
The Bayer Group got off to a very successful start to 2017 and generated strong sales and earnings growth in the first quarter. “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” CEO Werner Baumann said when he presented the interim report for ...
Majority stake maintained for the time being
Bayer AG is reducing its holding in Covestro AG from the current level of 64.2 percent. To this end, an accelerated bookbuilding process was started. Pricing and allocation of the shares are scheduled for March 1. Since the stock market listing of Covestro in 2015, the company’s share price has ...
Close of transaction expected by the end of 2017
Monsanto Company announced that at a special meeting of shareowners held today, shareowners of the company approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft. Under the terms of the merger agreement, Monsanto shareowners will receive $128 per share in cash ...